ATE453416T1 - Medizinischer stent mit einer kombination aus melatonin und paclitaxel - Google Patents

Medizinischer stent mit einer kombination aus melatonin und paclitaxel

Info

Publication number
ATE453416T1
ATE453416T1 AT07802809T AT07802809T ATE453416T1 AT E453416 T1 ATE453416 T1 AT E453416T1 AT 07802809 T AT07802809 T AT 07802809T AT 07802809 T AT07802809 T AT 07802809T AT E453416 T1 ATE453416 T1 AT E453416T1
Authority
AT
Austria
Prior art keywords
melatonin
paclitaxel
combination
medical stent
stent
Prior art date
Application number
AT07802809T
Other languages
English (en)
Inventor
Ronald Horvers
Original Assignee
Blue Medical Devices B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blue Medical Devices B V filed Critical Blue Medical Devices B V
Application granted granted Critical
Publication of ATE453416T1 publication Critical patent/ATE453416T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
AT07802809T 2006-08-23 2007-08-22 Medizinischer stent mit einer kombination aus melatonin und paclitaxel ATE453416T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2006008286 2006-08-23
PCT/EP2007/058743 WO2008023038A1 (en) 2006-08-23 2007-08-22 Medical stent provided with a combination of melatonin and paclitaxel

Publications (1)

Publication Number Publication Date
ATE453416T1 true ATE453416T1 (de) 2010-01-15

Family

ID=37866137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07802809T ATE453416T1 (de) 2006-08-23 2007-08-22 Medizinischer stent mit einer kombination aus melatonin und paclitaxel

Country Status (7)

Country Link
US (1) US20090258053A1 (de)
EP (1) EP2056897B1 (de)
JP (1) JP5385785B2 (de)
AT (1) ATE453416T1 (de)
CA (1) CA2660900A1 (de)
DE (1) DE602007004124D1 (de)
WO (1) WO2008023038A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007526322A (ja) * 2004-03-02 2007-09-13 マサチューセッツ インスティテュート オブ テクノロジー ナノセル薬物送達系
US20070053845A1 (en) * 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
US9265633B2 (en) * 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
JPWO2011096241A1 (ja) * 2010-02-02 2013-06-10 テルモ株式会社 生体内吸収性ステント
WO2015035387A1 (en) * 2013-09-09 2015-03-12 Arsenal Medical, Inc. Drug delivery systems and related methods
US11839698B2 (en) * 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
US10143779B2 (en) * 2014-05-16 2018-12-04 Terumo Kabushiki Kaisha Method of inhibiting thickening of vascular intima
DE102015000662B3 (de) 2015-01-23 2016-06-09 Jenoptik Laser Gmbh Laseranordnung mit Hilfsring
US20160374800A1 (en) * 2015-06-29 2016-12-29 Changcheng You Implantable scaffolds for treatment of sinusitis
US10232082B2 (en) 2015-06-29 2019-03-19 480 Biomedical, Inc. Implantable scaffolds for treatment of sinusitis
CA3060502C (en) 2017-04-20 2025-11-04 Lyra Therapeutics, Inc. ESTABLISHABLE SCAFFOLDING FOR SINUSITIS TREATMENT
IL297861A (en) 2020-05-08 2023-01-01 Psilera Inc Novel compositions of matter and pharmaceutical compositions
CN112048081B (zh) * 2020-08-19 2022-10-28 浙江工业大学 一种高强度全降解型木质素基高吸水性树脂及其制备方法
US11312684B1 (en) 2021-02-10 2022-04-26 Eleusis Therapeutics Us, Inc. Pharmaceutically acceptable salts of psilocin and uses thereof
WO2025099444A1 (en) * 2023-11-09 2025-05-15 Beckley Psytech Limited N-Acetylserotonin (NAS) Analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258121B1 (en) * 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
EP1246608A4 (de) * 2000-01-05 2005-05-18 Imarx Therapeutics Inc PHARMAZEUTISCHE ZUBEREITUNGEN ZUR VERABREICHUNG VON WIRKSTOFFEN MIT GERINGER WASSERLöSLICHKEIT
US6908622B2 (en) * 2001-09-24 2005-06-21 Boston Scientific Scimed, Inc. Optimized dosing for drug coated stents
KR20140148502A (ko) * 2002-12-09 2014-12-31 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
CA2536961A1 (en) * 2003-08-14 2005-02-24 Blue Medical Devices B.V. Endoluminal prosthesis comprising a therapeutic agent
US7220816B2 (en) * 2003-12-16 2007-05-22 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
US20060083768A1 (en) * 2004-09-28 2006-04-20 Atrium Medical Corporation Method of thickening a coating using a drug
US8609123B2 (en) * 2004-11-29 2013-12-17 Advanced Cardiovascular Systems, Inc. Derivatized poly(ester amide) as a biobeneficial coating

Also Published As

Publication number Publication date
JP5385785B2 (ja) 2014-01-08
JP2010501229A (ja) 2010-01-21
EP2056897B1 (de) 2009-12-30
US20090258053A1 (en) 2009-10-15
EP2056897A1 (de) 2009-05-13
CA2660900A1 (en) 2008-02-28
DE602007004124D1 (de) 2010-02-11
WO2008023038A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
DE602007004124D1 (de) Medizinischer stent mit einer kombination aus melatonin und paclitaxel
ATE502658T1 (de) Polymer-komposit-stent mit polymerteilchen
IL190383A0 (en) Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
EP2114303A4 (de) Gefässimplantate und verfahren zu deren herstellung
ATE500854T1 (de) Beschichtete medizinische vorrichtungen und verfahren zu ihrer herstellung
ATE490794T1 (de) Biologisch erodierbare endoprothese mit biostabilen anorganischen schichten
IL201284A (en) K3pi alpha pyridopyrimidinone inhibitor for use in combination with one or more therapeutic agents selected from Taxol, Rapamycin, Carboplatin and Arlutinib for cancer treatment
WO2006024488A3 (en) Medical stent provided with inhibitors of atp synthesis
WO2007106554A3 (en) Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds
MX2009012325A (es) Stent vascular.
WO2006110197A3 (en) Polymer biodegradable medical device
ATE518559T1 (de) Mikrobearbeitete medizinprodukte
ATE526048T1 (de) Beschichtetes biologisch abbaubares metallisches implantat
UA102669C2 (xx) Застосування інгібіторів dpp iv$применение ингибиторов dpp iv
EA201200143A1 (ru) Антибактериальная композиция для ротовой полости
NZ609223A (en) Vasoprotective and cardioprotective antidiabetic therapy
BRPI0814874A2 (pt) combinação de agente antimitótico e inibidor da aurora quinase como tratamento anticâncer.
NZ616957A (en) Hemostatic compositions and therapeutic regimens
ATE502663T1 (de) Medizinische vorrichtungen mit einem porösen metalloxid- oder metallmaterial und einer polymerbeschichtung zur freisetzung von therapeutika
MX2009003724A (es) Derivados de 2-aminocarbonil-piridina.
DE602005014651D1 (de) Medizinischer stent mit atp-synthesehemmern
BRPI0810647A2 (pt) " uso de trans carotenóides bipolares como um pré-tratamento e no tratamento de doença vascular periférica ".
DOP2006000235A (es) Derivados de acidos dicarboxilicos y su uso
ATE512970T1 (de) Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
GEP20125689B (en) New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkylsulfonamide derivatives of epipodophyllotoxin, preparation process thereof, and application thereat therapy as anticancer agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties